8月5日，信诺保险盘中下跌3.46%，报271.18美元/股，成交额6115.56万美元。消息面上，杰富瑞将信诺集团评级由"买入"下调至"持有"，目标价从336美元降至307美元，理由是盈利阻力不断增加且缺乏明确催化剂。此前一日，Raymond James亦将其评级由"强力买入"下调至"跑赢大市"，目标价从350美元降至320美元，指出业务增长放缓叠加药房福利管理业务持续面临逆风。
背景方面，信诺二季度财报虽超预期（调整后EPS 7.78美元，超预期2.37%），但管理层在电话会议中确认GLP-1处方增速放缓，药房业务承压。短期内连续遭两家机构下调评级，市场情绪偏谨慎。同行业中，西维斯健康跌6.49%，达维塔保健跌17.43%，板块整体承压。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.